A SCRUTINY ON ANTI-COVID ACTIVITY OF HETEROCYCLIC COMPOUNDS

The coronavirus disease 2019 (COVID-19) pandemic is one of the most serious health problems worldwide. It has caused serious calamities in the world since the blaze of SARS CoV in 2002 and then MERS CoV in 2012.The pandemic caused by SARS CoV-2, a coronavirus that began in China in December 2019, has caused a total of 24,066,076 cases. The World Health Organization reported 3.4 million deaths globally by December 2020.7,010,681 people have died so far from the corona virus COVID-19 outbreak as of April 13, 2024.Yet, there is no medication is feasible against it.For several decades, heterocyclic moeities have been extensively explored for their anticancer, antimalarial, anti-inflammatory, antituberculosis, antimicrobial, antidiabetic, antiviral and many other therapeutic abilities.Therefore, in this review, we emphasize the forecast the role of heterocyclic scaffolds in the design and discovery of the much-awaited anti-SARS CoV-2 therapy, by investigating research articles rendering various heterocyclic moieties.The heterocyclic moties outlined in the review may serve as important asset for the development of SARS coronavirus dealing approaches.